NASDAQ · Biotechnology

Coherus BioSciences Inc (CHRS)

$0.37 -4.47%
24 Oversold Daily RSI (14) · 19 Nov 2026

Moving averages

SMA 200$1.50-75.35%

Company profile

Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. The company is headquartered in Redwood City, California.

SectorHealthcare
IndustryBiotechnology
Market cap$90.02M
P/E ratioNone
EPS$-1.12
Beta1.054
Dividend yield0.00%
52-week high$2.62
52-week low$0.51

Similar stocks in Biotechnology

30 days of PRO Unlimited free, no card

RSI alerts for CHRS

An email when CHRS closes below RSI 30 or above 70. Nothing else.

Data last updated 13 November 2026 at 3:22 AM EST